Pizzuti Dana 4
4 · Crinetics Pharmaceuticals, Inc. · Filed Feb 24, 2025
Insider Transaction Report
Form 4
Pizzuti Dana
Chief Med and Dev Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-02-20+65,000→ 65,000 totalExercise: $36.86Exp: 2035-02-19→ Common Stock (65,000 underlying) - Award
Common Stock
2025-02-20+43,000→ 74,748 total
Footnotes (2)
- [F1]The transaction reported on this line involves the receipt of restricted stock units, which represent the right to receive shares of the Issuer's Common Stock, with 25% vesting annually beginning on March 15, 2026.
- [F2]The stock option shall vest and become exercisable in a series of forty-eight (48) successive equal monthly installments measured from the vesting commencement date of February 20, 2025.